85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT2071210016	11/07/2021	28/04/2021	Drug-drug interaction study of TAS-115 with lansoprazole in healthy subjects	Drug-drug interaction study of TAS-115 with lansoprazole in healthy subjects	Idiopathic pulmonary fibrosis	Day 1:TAS-115 will be orally administered. Day11-Day14:Lansoprazolewill be orally administered once a ...	Huang Jinhong	NULL	Complete	>= 20age old	< 40age old	Male	14	Phase 1	Japan
2	NCT04965298 (ClinicalTrials.gov)	June 16, 2021	7/7/2021	Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole	The Effectiveness and Risks of Treating People With Idiopathic Pulmonary Fibrosis With the Addition ...	Idiopathic Pulmonary Fibrosis	Drug: Lansoprazole;Other: Matched placebo	Norfolk and Norwich University Hospitals NHS Foundation Trust	Norwich Clinical Trials Unit	Recruiting	40 Years	N/A	All	298	Phase 3	United Kingdom
3	EUCTR2020-000041-14-GB (EUCTR)	19/06/2020	08/07/2020	Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole	The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition ...	Idiopathic Pulmonary Fibrosis MedDRA version: 21.1;Level: PT;Classification code 10021240;Term: Idio ...	Trade Name: Lansoprazole Product Name: Lansoprazole INN or Proposed INN: lansoprazole Other descriptive ...	Norfolk and Norwich University Hospitals NHS Foundation Trust	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	298	Phase 3	United Kingdom

First Previous1Next Last